SCHEMBL414679

SCHEMBL414679

CCCC=CCCCCC(=O)O

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.80
PPARD Q03181 6/20 0.80
PPARA Q07869 6/20 0.80
F7 P08709 6/20 0.80
F3 P13726 6/20 0.80
TERT O14746 3/20 0.80
PTPN1 P18031 3/20 0.80
HSD17B10 Q99714 3/20 0.80
FABP4 P15090 3/20 0.80
PTGS1 P23219 3/20 0.80
MAPT P10636 2/20 0.80
BLM P54132 2/20 0.80
LMNA P02545 2/20 0.80
ALOX15 P16050 2/20 0.80
DUSP3 P51452 2/20 0.80
CYP19A1 P11511 2/20 0.80
NR4A2 P43354 2/20 0.80
SIRT6 Q8N6T7 2/20 0.80
PTPN7 P35236 2/20 0.80
TDP1 Q9NUW8 2/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22320200 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL28959617 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL91182 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL2569796 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL2569791 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL2569794 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL30641896 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL414678 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL2690850 0.98 PPARG (0.84) PPARGPPARDPPARAF7F3
SCHEMBL2721190 0.98 PPARG (0.84) PPARGPPARDPPARAF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117904219-A Method for preparing cis-cyclooctaynol intermediate by enzyme catalysis 暨明医药科技(苏州)有限公司 2024-04-19 CN claimed
WO-2024014801-A1 METHOD FOR PREPARING SAPIENIC ACID, TRANS-ISOMER THEREOF, AND SAPIENIC ACID ESTER 전종열 2024-01-18 WO claimed
CN-117243359-A Osaka essence and preparation method and application thereof 天津春发生物科技集团有限公司 2023-12-19 CN claimed
US-20170172169-A1 SOY-BASED CHEESE IMPOSSIBLE FOOD INC (US) 2017-06-22 US claimed
EP-3107400-A1 SOY-BASED CHEESE Impossible Foods Inc. (US) 2016-12-28 EP claimed
WO-2015127388-A1 SOY-BASED CHEESE IMPOSSIBLE FOODS INC. (US) 2015-08-27 WO claimed
WO-2009131692-A1 SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2009-10-29 WO claimed
EP-1745791-A2 Treating cartilage/bone conditions with water-soluble strontium salts Osteologix A/S (DK) 2007-01-24 EP claimed
JP-59116247-A None JP disclosed
US-20260116914-A1 METHODS OF GENERATING NANOARRAYS AND MICROARRAYS NAUTILUS SUBSIDIARY INC (US) 2026-04-30 US disclosed
CN-117243359-B Osaka essence and preparation method and application thereof 天津春发生物科技集团有限公司 2026-04-03 CN disclosed
US-12522686-B2 Method for producing hydroxy-fatty-acid-based polyols U. WINDMÖLLER INNOVATION GMBH & CO. KG (DE) 2026-01-13 US disclosed
US-20250349136-A1 METHODS AND SYSTEMS FOR COMPUTATIONAL DECODING OF BIOLOGICAL, CHEMICAL, AND PHYSICAL ENTITIES NAUTILUS SUBSIDIARY INC (US) 2025-11-13 US disclosed
EP-4641061-A1 OIL-WELL METAL PIPE NIPPON STEEL CORPORATION (JP) 2025-10-29 EP disclosed
EP-1396534-A1 PERFUME COMPOSITION AND PROCESS FOR PRODUCING THE SAME SODA AROMATIC COMPANY, LIMITED (JP) 2004-03-10 EP disclosed
US-20030157228-A1 Perfume composition and process for producing the same SODA AROMATIC CO., LTD. (JP) 2003-08-21 US disclosed
EP-0381057-A2 Chemical composition for external application Sansho Seiyaku Co., Ltd. (JP) 1990-08-08 EP disclosed
EP-0355842-A2 External preparation Sansho Seiyaku Co., Ltd. (JP) 1990-02-28 EP disclosed
US-4609492-A ORGANOLEPTIC SODA AROMATIC COMPANY, LIMITED (JP) 1986-09-02 US disclosed
JP-S59116247-A PREPARATION OF UNSATURATED FATTY ACID SODA KORYO KK 1984-07-05 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260116914-A1 METHODS OF GENERATING NANOARRAYS AND MICROARRAYS SPPL2B, SNAP29, SPPL2A PPARG 4843/4885PPARD 4103/4885PPARA 4646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.